Taiwan has a good chance to play an important role in the biotechnology industry if the nation can effectively integrate its medical research infrastructure with its strengths in the electronics and information industries, an Industrial Technology Research Institute (ITRI) official said in Taipei yesterday.
By doing so, it could attract international companies to set up bioinformatics research and development (R&D) centers in Taiwan, Hsieh Liang-han (謝良翰), general director of ITRI’s international business center told the Taipei Times yesterday.
“Taiwan’s strength lies in its information and communications technology [ICT] industry and basic research. I believe if the nation’s biotechnology industry can integrate with the ICT industry, it will begin to develop at a faster pace,” Hsieh said at the sidelines of the 2008 APEC Biotechnology Conference organized by the ITRI.
What Taiwan lacks now in the field of biotechnology is the “link” in the industry value chain, Hsieh said.
For example, Taiwan may be strong in the basic research of liver disease, but the local biotech industry is still in the development stage, Hsieh said.
Stanley Chang (張世忠), chairman of the Taipei-based Medigen Biotechnology Corp (基亞生物科技), who was invited to give a speech at the conference, agreed.
“Taiwan is strong in a couple of research topics in the world, with liver cancer being our strongest point. Integrating Taiwan’s precision equipment and biotechnology is a new direction that we can seriously consider,” Chang told the Taipei Times yesterday after his speech.
To attract international companies, such as the Switzerland-based pharmaceutical companies Novartis International AG and Roche Applied Science to set up their R&D centers in Taiwan, Hsieh said the government would have to first set up a few centers of excellence, such as in liver disease.
The conference took place at the Taipei International Convention Center yesterday, with “adding value to biomedical translational medicine” being its main theme. Hsieh said ITRI’s international business center would focus on linking the laboratory and the “patient’s bedside” this year — often referred to as “bench to bedside” — and encouraging transregional cooperation.
Biotech experts from seven foreign countries were invited by ITRI to share their experiences and national policies regarding translational medicine at the conference yesterday, in an effort to foster cross-regional interaction and translational medicine collaboration in the Asia-Pacific region.
SECOND-RATE: Models distilled from US products do not perform the same as the original and undo measures that ensure the systems are neutral, the US’ cable said The US Department of State has ordered a global push to bring attention to what it said are widespread efforts by Chinese companies, including artificial intelligence (AI) start-up DeepSeek (深度求索), to steal intellectual property from US AI labs, according to a diplomatic cable. The cable, dated Friday and sent to diplomatic and consular posts around the world, instructs diplomatic staff to speak to their foreign counterparts about “concerns over adversaries’ extraction and distillation of US AI models.” Distillation is the process of training smaller AI models using output from larger, more expensive ones to lower the costs of training a powerful new
Shares of Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) have repeatedly hit new highs, but an equity analyst said the stock’s valuation remains within a reasonable range and any pullback would likely be technical. The contract chipmaker’s historical price-to-earnings (P/E) ratio has ranged between 20 and 30, Cathay Futures Consultant Co (國泰證期) analyst Tsai Ming-han (蔡明翰) told Central News Agency. With market consensus projecting that TSMC would post earnings per share of about NT$100 (US$3.17) this year, supported by strong global demand for artificial intelligence (AI) applications, and the stock currently trading at a P/E ratio of below 25, Tsai said the valuation
The artificial intelligence (AI) boom has triggered a seismic reshuffling of global equity markets, with Taiwan and South Korea muscling past European nations one by one. With its stock market now valued at nearly US$4.3 trillion, Taiwan surpassed the UK, Europe’s biggest market, earlier this month, data compiled by Bloomberg showed. South Korea is about US$140 billion away from doing the same. The tech-heavy Asian markets have shot past Germany and France in the past seven months. The shift is largely down to massive gains in shares of three companies that provide essential hardware for AI: Taiwan Semiconductor Manufacturing Co (TSMC, 台積電),
The US Department of Commerce last week ordered multiple chip equipment companies to halt shipments of certain tools to China’s second-largest chipmaker, Hua Hong Semiconductor Ltd (華虹半導體), its latest action to slow the country’s development of advanced chips, two people familiar with the matter said. The department sent letters to at least a handful of companies informing them of restrictions on tools and other materials destined for two Hua Hong facilities US officials believe make China’s most sophisticated chips, the people said. Top US chip equipment companies Lam Research Corp, Applied Materials Inc and KLA Corp, each of which has significant
RSS